Venus Concept Inc. (NASDAQ:VERO – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,450,000 shares, a growth of 1,956.7% from the October 15th total of 70,500 shares. Currently, 35.1% of the shares of the company are sold short. Based on an average daily volume of 1,690,000 shares, the days-to-cover ratio is currently 0.9 days.
Insiders Place Their Bets
In related news, major shareholder Michael Willingham Masters sold 71,368 shares of the company’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $0.64, for a total transaction of $45,675.52. Following the completion of the sale, the insider now directly owns 22,383 shares of the company’s stock, valued at approximately $14,325.12. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 57.98% of the company’s stock.
Hedge Funds Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its position in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 87.41% of the company’s stock.
Venus Concept Stock Down 7.4 %
Venus Concept (NASDAQ:VERO – Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported ($1.39) earnings per share for the quarter. The company had revenue of $16.58 million for the quarter. As a group, sell-side analysts anticipate that Venus Concept will post -6.37 earnings per share for the current year.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Featured Stories
- Five stocks we like better than Venus Concept
- Investing In Preferred Stock vs. Common Stock
- 3 Solar Stocks at Bargain Prices: Big Opportunities Ahead
- What is a Dividend King?
- Is Bitcoin’s Trump Card a Boom or Bust?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Cloudflare Is a Solid Buy for 2025
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.